1
|
Swantek JL, Christerson L and Cobb MH:
Lipopolysaccharide-induced tumor necrosis factor-α promoter
activity is inhibitor of nuclear factor-κB kinase-dependent. J Biol
Chem. 274:11667–11671. 1999. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sharma J, Al-Omran A and Parvathy S: Role
of nitric oxide in inflammatory diseases. Inflammopharmacology.
15:252–259. 2007. View Article : Google Scholar
|
3
|
Bogdan C: Nitric oxide and the immune
response. Nat Immunol. 2:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bogdan C, Röllinghoff M and Diefenbach A:
The role of nitric oxide in innate immunity. Immunol Rev.
173:17–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zamora R, Vodovotz Y and Billiar TR:
Inducible nitric oxide synthase and inflammatory diseases. Mol Med.
6:347–373. 2000.PubMed/NCBI
|
6
|
Sakai K, Suzuki H, Oda H, et al:
Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage:
critical dimerization of inducible nitric-oxide synthase. J Biol
Chem. 281:17736–17742. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Luyendyk JP, Schabbauer GA, Tencati M,
Holscher T, Pawlinski R and Mackman N: Genetic analysis of the role
of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and
tissue factor gene expression in monocytes/macrophages. J Immunol.
180:4218–4226. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Pahan K, Raymond JR and Singh I:
Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide
synthase in lipopolysaccharide-or cytokine-stimulated C6 glial
cells. J Biol Chem. 274:7528–7536. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Pahan K, Liu X, Wood C and Raymond JR:
Expression of a constitutively active form of phosphatidylinositol
3-kinase inhibits the induction of nitric oxide synthase in human
astrocytes. FEBS Lett. 472:203–207. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Teshima S, Nakanishi H, Nishizawa M, et
al: Up-regulation of IL-1 receptor through PI3K/Akt is essential
for the induction of iNOS gene expression in hepatocytes. J
Hepatol. 40:616–623. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Choudhary C, Kumar C, Gnad F, et al:
Lysine acetylation targets protein complexes and co-regulates major
cellular functions. Science. 325:834–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ghizzoni M, Haisma HJ, Maarsingh H and
Dekker FJ: Histone acetyltransferases are crucial regulators in
NF-κB mediated inflammation. Drug Discov Today. 16:504–511. 2011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Yang WM, Tsai SC, Wen YD, Fejér G and Seto
E: Functional domains of histone deacetylase-3. J Biol Chem.
277:9447–9454. 2002. View Article : Google Scholar : PubMed/NCBI
|
14
|
Roth SY, Denu JM and Allis CD: Histone
acetyltransferases. Annu Rev Biochem. 70:81–120. 2001. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lin HY and Chen CS, Lin SP, Weng JR and
Chen CS: Targeting histone deacetylase in cancer therapy. Med Res
Rev. 26:397–413. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Raja B: Veratric acid, a phenolic acid
attenuates blood pressure and oxidative stress in l-NAME induced
hypertensive rats. Eur J Pharmacol. 671:87–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kim MY, Seguin P, Ahn JK, et al: Phenolic
compound concentration and antioxidant activities of edible and
medicinal mushrooms from Korea. J Agr Food Chem. 56:7265–7270.
2008. View Article : Google Scholar
|
18
|
Choi WS, Shin PG, Lee JH and Kim GD: The
regulatory effect of veratric acid on NO production in
LPS-stimulated RAW264.7 macrophage cells. Cell Immunol.
280:164–170. 2012. View Article : Google Scholar
|
19
|
Stiehl DP, Fath DM, Liang D, Jiang Y and
Sang N: Histone deacetylase inhibitors synergize p300
autoacetylation that regulates its transactivation activity and
complex formation. Cancer Res. 67:2256–2264. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Huang WC and Chen CC: Akt phosphorylation
of p300 at Ser-1834 is essential for its histone acetyltransferase
and transcriptional activity. Mol Cell Biol. 25:6592–6602. 2005.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Takasawa S, Ikeda T, Akiyama T, et al:
Cyclin D1 activation through ATF-2 in Reg-induced pancreatic β-cell
regeneration. FEBS Lett. 580:585–591. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kawasaki H, Schiltz L, Chiu R, et al:
ATF-2 has intrinsic histone acetyltransferase activity which is
modulated by phosphorylation. Nature. 405:195–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
23
|
Miao F, Gonzalo IG, Lanting L and
Natarajan R: In vivo chromatin remodeling events leading to
inflammatory gene transcription under diabetic conditions. J Biol
Chem. 279:18091–18097. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Geering B, Cutillas PR, Nock G, Gharbi SI
and Vanhaesebroeck B: Class IA phosphoinositide 3-kinases are
obligate p85–p110 heterodimers. Proc Natl Acad Sci USA.
104:7809–7814. 2007. View Article : Google Scholar
|
25
|
Koyasu S: The role of PI3K in immune
cells. Nat Immunol. 4:313–319. 2003. View Article : Google Scholar : PubMed/NCBI
|
26
|
Monick MM, Carter AB, Robeff PK, Flaherty
DM, Peterson MW and Hunninghake GW: Lipopolysaccharide activates
Akt in human alveolar macrophages resulting in nuclear accumulation
and transcriptional activity of β-catenin. J Immunol.
166:4713–4720. 2001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Tsukamoto K, Hazeki K, Hoshi M, et al:
Critical roles of the p110β subtype of phosphoinositide 3-kinase in
lipopolysaccharide-induced Akt activation and negative regulation
of nitrite production in RAW 264.7 cells. J Immunol. 180:2054–2061.
2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Sheu ML, Chao KF, Sung YJ, Lin WW,
Lin-Shiau SY and Liu SH: Activation of phosphoinositide 3-kinase in
response to inflammation and nitric oxide leads to the
up-regulation of cyclooxygenase-2 expression and subsequent cell
proliferation in mesangial cells. Cell Signal. 17:975–984. 2005.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Chiou WF, Don MJ, Liao JF and Wei BL:
Psoralidin inhibits LPS-induced iNOS expression via repressing
Syk-mediated activation of PI3K-IKK-IκB signaling pathways. Eur J
Pharmacol. 650:102–109. 2011. View Article : Google Scholar
|
30
|
Chen J, Halappanavar S, St-Germain J,
Tsang B and Li Q: Role of Akt/protein kinase B in the activity of
transcriptional coactivator p300. Cell Mol Life Sci. 61:1675–1683.
2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Liu Y, Denlinger CE, Rundall BK, Smith PW
and Jones DR: Suberoylanilide hydroxamic acid induces Akt-mediated
phosphorylation of p300, which promotes acetylation and
transcriptional activation of RelA/p65. J Biol Chem.
281:31359–31368. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Deng WG and Wu KK: Regulation of inducible
nitric oxide synthase expression by p300 and p50 acetylation. J
Immunol. 171:6581–6588. 2003. View Article : Google Scholar : PubMed/NCBI
|
33
|
Bruhat A, Chérasse Y, Maurin AC, et al:
ATF2 is required for amino acid-regulated transcription by
orchestrating specific histone acetylation. Nucleic Acid Res.
35:1312–1321. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Chang PC, Chen TH, Chang CJ, Hou CC, Chan
P and Lee HM: Advanced glycosylation end products induce inducible
nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent
pathway. Kidney Int. 65:1664–1675. 2004. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lundh M, Christensen D, Nielsen MD, et al:
Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced
beta cell apoptosis in INS-1 cells and dispersed primary islets
from rats and are differentially regulated in the islets of type 1
diabetic children. Diabetologia. 55:2421–2431. 2012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Chen LF, Fischle W, Verdin E and Greene
WC: Duration of nuclear NF-κB action regulated by reversible
acetylation. Science. 293:1653–1657. 2001. View Article : Google Scholar
|
37
|
Yu Z, Zhang W and Kone BC: Histone
deacetylases augment cytokine induction of the iNOS gene. J Am Soc
Nephrol. 13:2009–2017. 2002. View Article : Google Scholar : PubMed/NCBI
|
38
|
Ashburner BP, Westerheide SD and Baldwin
AS: The p65 (RelA) subunit of NF-κB interacts with the histone
deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively
regulate gene expression. Mol Cell Biol. 21:7065–7077. 2001.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Barter MJ, Pybus L, Litherland GJ, et al:
HDAC-mediated control of ERK-and PI3K-dependent TGF-β-induced
extracellular matrix-regulating genes. Matrix Biol. 29:602–612.
2010. View Article : Google Scholar : PubMed/NCBI
|
40
|
Lv WW, Wei HM, Wang DL, Ni JQ and Sun FL:
Depletion of histone deacetylase 3 antagonizes PI3K-mediated
overgrowth of Drosophila organs through the acetylation of histone
H4 at lysine 16. J Cell Sci. 125:5369–5378. 2012. View Article : Google Scholar : PubMed/NCBI
|
41
|
Hargreaves DC, Horng T and Medzhitov R:
Control of inducible gene expression by signal-dependent
transcriptional elongation. Cell. 138:129–145. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Modak R, Mitra SD, Krishnamoorthy P, et
al: Histone H3K14 and H4K8 hyperacetylation is associated with
Escherichia coli-induced mastitis in mice. Epigenetics. 7:492–501.
2012. View Article : Google Scholar : PubMed/NCBI
|
43
|
Tsaprouni LG, Ito K, Powell JJ, Adcock IM
and Punchard N: Differential patterns of histone acetylation in
inflammatory bowel diseases. J Inflamm. 8:12011. View Article : Google Scholar
|
44
|
Ito K, Barnes PJ and Adcock IM:
Glucocorticoid receptor recruitment of histone deacetylase 2
inhibits interleukin-1β-induced histone H4 acetylation on lysines 8
and 12. Mol Cell Biol. 20:6891–6903. 2000. View Article : Google Scholar : PubMed/NCBI
|
45
|
Lowenstein CJ, Alley EW, Raval P, et al:
Macrophage nitric oxide synthase gene: two upstream regions mediate
induction by interferon gamma and lipopolysaccharide. Proc Natl
Acad Sci USA. 90:9730–9734. 1993. View Article : Google Scholar : PubMed/NCBI
|
46
|
Yu Z and Kone BC: Targeted histone H4
acetylation via phosphoinositide 3-kinase-and
p70s6-kinase-dependent pathways inhibits iNOS induction in
mesangial cells. Am J Physiol Renal Physiol. 290:F496–F502. 2006.
View Article : Google Scholar
|